A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AB801 in Healthy Volunteers
Clinical trial NCT06004921 · COMPLETED
Trial details
- NCT number
- NCT06004921
- Sponsor
- Arcus Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2024-02-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.